Income investors looking for a dividend boost may want to read on.
That's because listed below are two ASX dividend stocks that analysts are recommending as buys.
Here's what sort of yields you can expect from these stocks next year and the year after:
Image source: Getty Images
Aurizon Holdings Ltd (ASX: AZJ)
The first ASX dividend stock that has been named as a buy is Aurizon. It is Australia's largest rail freight operator, transporting hundreds of millions of tonnes of Australian commodities each year across 5,100 kilometres of rail track.
Macquarie sees the company as a top option for income investors right now. It has an outperform rating and a $4.04 price target on its shares.
As for dividends, the broker is forecasting partially franked dividends of 19.1 cents per share in FY 2024 and then 24.5 cents per share in FY 2025. Based on the latest Aurizon share price of $3.81, this will mean yields of 5% and 6.4%, respectively.
Healthco Healthcare and Wellness REIT (ASX: HCW)
Another ASX dividend stock that has been named as a buy is Healthco Healthcare and Wellness REIT.
It is a leading health and wellness-focused real estate investment trust with exposure to a diversified portfolio underpinned by attractive megatrends.
Morgans is forecasting dividends per share of 8 cents in both FY 2024 and FY 2025. Based on the current Healthco Healthcare and Wellness REIT unit price of $1.49, this will mean yields of 5.35% in both financial years.
In addition, the broker sees plenty of upside for its shares over the next 12 months. A recent note reveals that it currently has an add rating and a $1.67 price target on its shares.
